These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7700242)

  • 1. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
    Choudhary MS; Sachs N; Uluer A; Glennon RA; Westkaemper RB; Roth BL
    Mol Pharmacol; 1995 Mar; 47(3):450-7. PubMed ID: 7700242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
    Choudhary MS; Craigo S; Roth BL
    Mol Pharmacol; 1993 May; 43(5):755-61. PubMed ID: 8388989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
    Nelson DL; Lucaites VL; Audia JE; Nissen JS; Wainscott DB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model.
    Roth BL; Choudhary MS; Khan N; Uluer AZ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):576-83. PubMed ID: 9023266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor.
    Boess FG; Monsma FJ; Meyer V; Zwingelstein C; Sleight AJ
    Mol Pharmacol; 1997 Sep; 52(3):515-23. PubMed ID: 9284367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14.
    Ozenberger BA; Hadcock JR
    Mol Pharmacol; 1995 Jan; 47(1):82-7. PubMed ID: 7838136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
    Chanda PK; Minchin MC; Davis AR; Greenberg L; Reilly Y; McGregor WH; Bhat R; Lubeck MD; Mizutani S; Hung PP
    Mol Pharmacol; 1993 Apr; 43(4):516-20. PubMed ID: 8474430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution to activity of histidine-aromatic, amide-aromatic, and aromatic-aromatic interactions in the extended catalytic site of cysteine proteinases.
    Brömme D; Bonneau PR; Purisima E; Lachance P; Hajnik S; Thomas DY; Storer AC
    Biochemistry; 1996 Apr; 35(13):3970-9. PubMed ID: 8672429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of aromatic phenylalanine residues in binding carotenoid to light-harvesting model and wild-type complexes.
    García-Martín A; Pazur A; Wilhelm B; Silber M; Robert B; Braun P
    J Mol Biol; 2008 Sep; 382(1):154-66. PubMed ID: 18640123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS; Zheng MQ; Murray TF; Aldrich JV
    J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
    Xie J; Dernovici S; Ribeiro P
    J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
    Harris JM; McIntosh EM; Muscat GE
    J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
    Pauwels PJ; Gouble A; Wurch T
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation to phenylalanine of tyrosine 371 in tyrosine hydroxylase increases the affinity for phenylalanine.
    Daubner SC; Fitzpatrick PF
    Biochemistry; 1998 Nov; 37(46):16440-4. PubMed ID: 9819237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of aromatic and charged residue substitutions in the RNA binding domains of the yeast poly(A)-binding protein.
    Deardorff JA; Sachs AB
    J Mol Biol; 1997 May; 269(1):67-81. PubMed ID: 9193001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine binding site in the vesicular acetylcholine transporter.
    Ojeda AM; Kolmakova NG; Parsons SM
    Biochemistry; 2004 Sep; 43(35):11163-74. PubMed ID: 15366926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the substrate-recognition mode of aromatic amino acid aminotransferase by combined use of quasisubstrates and site-directed mutagenesis: systematic hydroxy-group addition/deletion studies to probe the enzyme-substrate interactions.
    Hayashi H; Inoue K; Mizuguchi H; Kagamiyama H
    Biochemistry; 1996 May; 35(21):6754-61. PubMed ID: 8639626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.
    Barker EL; Blakely RD
    Mol Pharmacol; 1996 Oct; 50(4):957-65. PubMed ID: 8863842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.